Medivir AB – Interim Report January – June 2018

HUDDINGE, Sweden, July 25, 2018 /PRNewswire/ — Successful progression of clinical projects April – June Significant events during the quarter Positive top-line results from the MIV-711 osteoarthritis phase IIa extension study. The study met the primary endpoint, demonstrating that…

Source: https://www.prnewswire.com:443/news-releases/medivir-ab–interim-report-january–june-2018-300686208.html

About the Author

has written 39590 stories on this site.

Copyright © 2010 Business and Corporate News.